Prospective bicenter outpatient study demonstrates effective treatment for benign prostatic hyperplasia, suggesting a minimally invasive option.
Urethra-sparing TPTA has proven to be a safe, feasible, and effective treatment for LUTS and may represent a minimally invasive and effective alternative for BPH.
No takes yet. Share an insight, caveat, or question.
Nunes et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: